Study of some biochemical factors among patients with Hepatitis C virus in Diyala Governorate

Authors

  • Saba Adnan University of Diyala

DOI:

https://doi.org/10.24237/04.01.829

Keywords:

Hepatitis C virus, anti- HCV Abs, hepatitis infection, ALT liver enzyme and AST liver enzyme

Abstract

The HCV leads Hepatitis can be either acute or chronic, with severity levels that can vary from a mild illness lasting a couple of weeks to a severe, lifelong condition, and it's a leading cause of liver cancer. HCV is transmitted through blood, and the most common way people get infected is by coming into contact with small amounts of blood. This study set out to look into how widespread the serological marker (anti-HCV Ab) is among the groups being examined.to

  (renal dialysis patients, thalassemia patients, blood donor and healthy control) in Diyala, Iraq. The current study was held in Diyala province between the times/ from January/2025 to September / 2025. This study included 360 participants. The Mean ± SD of age was 30.0 ±17.5 years with a range (3-69) years. The majority are men, (76.9% versus ±23.1%). This study were included four groups (90 patients under renal dialysis, 90 patients with thalassemia blood donors group consist of 90 individuals and another 90 individuals were included as healthy control). Special survey was pre-constructed to collect information regarding age, sex, residence and education level. The information was collected through short personal interview with patients. The results in this study showed 36 (10%) were positive for anti-HCV Abs with 32.2% and 7.8% among the renal dialysis and thalassemia groups respectively with a statistically high difference (P= 0.0001). However, all participants in the blood donors and healthy individuals were negative for anti-HCV Ab. According to social factors the results of anti-HCV Ab founded the age, the results showed that the  anti-HCV Ab positivity rate was significantly higher among 50-59 years old compared to other age groups (P= 0.0001). While the other social factors (gender, residence and education) the results was statistically insignificant. Finally, Results revealed the distribution of anti-HCV Ab positivity rate according to biochemical markers (Glucose test, Blood urea test, Creatinine test, Total bilirubin test, Albumin test, Total protein test, ALT test and AST test) were statistical analysis significantly higher (P value= 0.0001) among all biochemical markers according to positivity rate of anti-HCV Ab. The conclusion from this study, the prevalence of HCV infection was high among study groups in Diyala province/Iraq and HCV infection progressively compromises liver function.  

Downloads

Download data is not yet available.

Author Biography

  • Saba Adnan, University of Diyala

    M. Saba Adnan Abbas    is Assistant at College of Science, University of Diyala, Iraq. She received the B.Sc. degree in biological science from the University of ALmustansiria and M.Sc. degree from Saratov university/Russia. . She has published several scientific papers in national, international conferences and journals. She can be contacted at email: sabaadnan@uodiyala.edu.iq.

References

[1] C. Shen, X. Jiang, M. Li, and Y. Luo, "Hepatitis virus and hepatocellular carcinoma: recent advances," Cancers, vol. 15, no. 2, p. 533, 2023.

[2] L. C. K. BOMGNING, M. K. TSAGUE, A. L. FOTIO, E. P. NGUELEFACK-MBUYO, and T. B. NGUELEFACK, "Chapter seven viral hepatitis infection: current facts and figures, and contribution of the african pharmacopeia," The Transformative Development of Postcolonial Africa: Voices of Pure and Natural Scientists, p. 134, 2024.

[3] L. Buchardt et al., "Update on hepatitis E virus infection 2025: insights from an International symposium," Liver International, vol. 45, no. 11, p. e70364, 2025.

[4] N. Abu-Freha et al., "Chronic hepatitis C: Diagnosis and treatment made easy," European Journal of General Practice, vol. 28, no. 1, pp. 102-108, 2022.

[5] A. Zanetto, E. Campello, M. Senzolo, and P. Simioni, "The evolving knowledge on primary hemostasis in patients with cirrhosis: a comprehensive review," Hepatology, vol. 79, no. 2, pp. 460-481, 2024.

[6] F. Zeng et al., "Silencing progestagen-associated endometrial protein (PAEP) suppresses sorafenib resistance and enhances sorafenib-induced ferroptosis in hepatocellular carcinoma," Liver Research, 2025.

[7] T. Holly et al., "Hepatitis C virus genotype 4 cluster with suspected sexual transmission in Chicago, IL," BMC Public Health, 2025.

[8] A. A. Rabaan et al., "Overview of hepatitis C infection, molecular biology, and new treatment," Journal of infection and public health, vol. 13, no. 5, pp. 773-783, 2020.

[9] C. Schmidbauer et al., "Epidemiological trends in HCV transmission and prevalence in the Viennese HIV+ population," Liver International, vol. 40, no. 4, pp. 787-796, 2020.

[10] B. L. Lane et al., "Hepatitis C Care in the Greater New Orleans Area: Patient Perspectives on the Barriers and Facilitators to Care," Journal of health care for the poor and underserved, vol. 36, no. 1, pp. 257-283, 2025.

[11] S. Rawi and G. Y. Wu, "Pathogenesis of thrombocytopenia in chronic HCV infection: a review," Journal of clinical and translational hepatology, vol. 8, no. 2, p. 184, 2020.

[12] M. Nogales-Garcia et al., "Elimination of hepatitis C virus in a prison: An 18-year experience," Enfermedades infecciosas y microbiologia clinica (English ed.), vol. 42, no. 5, pp. 236-241, 2024.

[13] N. S. Bhatt, A. K. Prajapati, and G. B. Shah, "Exploring animal models and in vitro models for liver diseases: a review," Egyptian Liver Journal, vol. 15, no. 1, p. 55, 2025.

[14] A. M. Hussein, M. M. Afifi, A. A. Wardany, H. K.-A. Ramadan, and N. Gaber, "Expression of phosphate and Tensin homolog gene in hepatitis C Virus Induced hepatocellular carcinoma," Microbial Biosystems, vol. 10, no. 2, 2025.

[15] Y. Li et al., "Global, Regional and National Burden of Chronic Hepatitis C, 1990–2021: A Systematic Analysis for the GBD Study 2021," Journal of Viral Hepatitis, vol. 32, no. 8, p. e70053, 2025.

[16] Y. Zhang, J. Stokes, L. Anselmi, P. Bower, and J. Xu, "Can integrated care interventions strengthen primary care and improve outcomes for patients with chronic diseases? A systematic review and meta-analysis," Health Research Policy and Systems, vol. 23, no. 1, p. 5, 2025.

[17] R. S. A. Hafez, A. A. Semeya, R. Elgamal, and A. A. Othman, "Direct-acting antiviral therapy reduces variceal rebleeding and improves liver function in hepatitis C virus-related cirrhosis: A multicenter retrospective cohort study," World Journal of Hepatology, vol. 17, no. 11, p. 110638, 2025.

[18] D. J. Gyunda, "Seroprevalence, Clinical Patterns and Factors Associated with Hepatitis B and C Virus Infections Among Patients With Chronic Liver Diseases in Dodoma Region, Tanzania," University of Dodoma (Tanzania), 2023.

[19] P. Malhotra, "Spectrum of HBV & HCV Among Blood Donors and Dialysis Patients at Tertiary Care Center of Northeren India," Japanese Journal of Gastroenterology, 2025.

[20] S. T. Sangeetha, A. S. Priya, and S. T. Sangeetha, "Study of prevalence of Hepatitis B and Hepatitis C and HCV genotypes in hemodialysis patients."

[21] A. K. Chakrabarty, A. Al Mamun, M. A. M. Swapnil, and A. J. Tarafdar, "Prevalence of Anti-HCV Seropositivity among Dialysis Patients in Bangladesh," The Planet, vol. 6, no. 02, pp. 344-350, 2022.

[22] M. Kumar and S. Jain, "Prevalence of Infections Caused by Hepatitis B Virus, Hepatitis C Virus and Their Co-Infection in A Tertiary Care Centre, Delhi, India," Journal of Epidemiology and Public Health, vol. 10, no. 1, pp. 83-90, 2025.

[23] P. Ergen, Ö. Aydın, A. N. Erbakan, and S. A. Ejder, "Overview of blood-borne viral infections in hemodialysis patients: hepatitis B, hepatitis C, human immunodeficiency virus infections," Journal of Health Sciences and Medicine, vol. 5, no. 1, pp. 195-200, 2022.

164

Downloads

Published

2026-01-30

How to Cite

Adnan, S. (2026). Study of some biochemical factors among patients with Hepatitis C virus in Diyala Governorate. ٍِASJ - Academic Science Journal, 4(1), 158-164. https://doi.org/10.24237/04.01.829

Similar Articles

31-40 of 74

You may also start an advanced similarity search for this article.